Mark J. Slivjak

510 total citations
22 papers, 379 citations indexed

About

Mark J. Slivjak is a scholar working on Molecular Biology, Physiology and Immunology. According to data from OpenAlex, Mark J. Slivjak has authored 22 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Physiology and 5 papers in Immunology. Recurrent topics in Mark J. Slivjak's work include Immune Response and Inflammation (5 papers), Nitric Oxide and Endothelin Effects (4 papers) and Receptor Mechanisms and Signaling (4 papers). Mark J. Slivjak is often cited by papers focused on Immune Response and Inflammation (5 papers), Nitric Oxide and Endothelin Effects (4 papers) and Receptor Mechanisms and Signaling (4 papers). Mark J. Slivjak collaborates with scholars based in United States and Canada. Mark J. Slivjak's co-authors include Edward F. Smith, Klaus Esser, Joan O'Leary Bartus, Uma Prabhakar, John C. Lee, David B. Lipshutz, Harvey M. Rosen, Hadar Rosen, G. Feuerstein and Reuven Rabinovici and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Plastic & Reconstructive Surgery and European Journal of Pharmacology.

In The Last Decade

Mark J. Slivjak

22 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark J. Slivjak United States 11 130 88 82 77 57 22 379
Maria A. Rivelli United States 14 137 1.1× 60 0.7× 63 0.8× 212 2.8× 110 1.9× 27 490
Artur-Aron Weber Germany 8 126 1.0× 55 0.6× 75 0.9× 34 0.4× 18 0.3× 8 446
T Matsushima Japan 11 87 0.7× 169 1.9× 20 0.2× 26 0.3× 54 0.9× 30 474
A. Shino Japan 11 142 1.1× 97 1.1× 27 0.3× 111 1.4× 45 0.8× 19 425
Koh‐ichiro Kinugawa Japan 10 165 1.3× 40 0.5× 59 0.7× 106 1.4× 21 0.4× 14 357
Jose Gasalla-Herraiz United States 11 196 1.5× 67 0.8× 13 0.2× 46 0.6× 57 1.0× 15 438
Darijana Horvat United States 15 172 1.3× 80 0.9× 131 1.6× 64 0.8× 23 0.4× 27 581
T. Viganò Italy 15 137 1.1× 42 0.5× 76 0.9× 320 4.2× 91 1.6× 41 626
Leonóra Himer Hungary 8 127 1.0× 56 0.6× 180 2.2× 26 0.3× 49 0.9× 8 557

Countries citing papers authored by Mark J. Slivjak

Since Specialization
Citations

This map shows the geographic impact of Mark J. Slivjak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Slivjak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Slivjak more than expected).

Fields of papers citing papers by Mark J. Slivjak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark J. Slivjak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Slivjak. The network helps show where Mark J. Slivjak may publish in the future.

Co-authorship network of co-authors of Mark J. Slivjak

This figure shows the co-authorship network connecting the top 25 collaborators of Mark J. Slivjak. A scholar is included among the top collaborators of Mark J. Slivjak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark J. Slivjak. Mark J. Slivjak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nambi, Ponnal, et al.. (1994). Endotoxin-Mediated Changes in Plasma Endothelin Concentrations, Renal Endothelin Receptor and Renal Function. Pharmacology. 48(3). 147–156. 13 indexed citations
2.
Prabhakar, Uma, David B. Lipshutz, Joan O'Leary Bartus, et al.. (1994). Characterization of cAMP-dependent inhibition of LPS-induced TNFα production by rolipram, a specific phosphodiesterase IV (PDE IV) inhibitor. International Journal of Immunopharmacology. 16(10). 805–816. 122 indexed citations
3.
Smith, Edward F., et al.. (1993). Fluid Resuscitation Improves Survival of Endotoxemic or Septicemic Rats: Possible Contribution of Tumor Necrosis Factor. Pharmacology. 46(5). 254–267. 16 indexed citations
4.
DiMartino, Michael J., Mark J. Slivjak, Klaus Esser, et al.. (1993). Adjuvant arthritic (AA) rats exhibit enhanced endotoxin-induced plasma TNF (EIPT) levels. Inflammation Research. 39(S1). C58–C60. 3 indexed citations
5.
6.
7.
Yue, Tongpeng, Edward F. Smith, Eliot H. Ohlstein, et al.. (1992). Pharmacological profile of G619, a new platelet aggregation inhibitor. Thrombosis Research. 66(4). 331–347. 2 indexed citations
8.
Smith, Edward F., Mark J. Slivjak, Joan O'Leary Bartus, & Klaus Esser. (1991). SK&F 86002 Inhibits Tumor Necrosis Factor Formation and Improves Survival in Endotoxemic Rats. Journal of Cardiovascular Pharmacology. 18(5). 721–728. 13 indexed citations
9.
Nichols, Andrew J., Teresa S. Sellers, D.E. Griswold, et al.. (1991). Reduction in Myocardial Ischemic/Reperfusion Injury and Neutrophil Accumulation After Therapeutic Administration of Streptokinase. Journal of Cardiovascular Pharmacology. 18(5). 729–738. 8 indexed citations
10.
11.
Rabinovici, Reuven, Tongpeng Yue, Michel Y. Farhat, et al.. (1990). Platelet activating factor (PAF) and tumor necrosis factor-alpha (TNF alpha) interactions in endotoxemic shock: studies with BN 50739, a novel PAF antagonist.. Journal of Pharmacology and Experimental Therapeutics. 255(1). 256–263. 50 indexed citations
12.
Smith, Edward F. & Mark J. Slivjak. (1989). Evidence for high and low affinity leukotriene D4 receptors mediating vascular responses in the conscious rat. European Journal of Pharmacology. 159(3). 297–301. 3 indexed citations
13.
Egan, J., D.E. Griswold, Leonard M. Hillegass, et al.. (1989). Selective antagonism of peptidoleukotriene response does not reduce myocardial damage opr neutrophil accumulation following coronary artery occlusion with reperfusion. Prostaglandins. 37(5). 597–613. 9 indexed citations
14.
15.
Lento, Paul, et al.. (1989). Beneficial effects of a specific leukotriene receptor antagonist in splanchnic artery occlusion shock. European Journal of Pharmacology. 165(2-3). 241–249. 1 indexed citations
16.
Esser, Klaus, et al.. (1989). Cardiovascular and pulmonary effects of human recombinant tumor necrosis factor in the conscious rat.. PubMed. 28(4). 369–84. 16 indexed citations
17.
Lappe, Rodney W., et al.. (1987). Hemodynamic effects of calcitonin gene-related peptide in conscious rats. Regulatory Peptides. 19(5-6). 307–312. 27 indexed citations
18.
Rosen, Harvey M., et al.. (1987). The Role of Perfusion Washout in Limb Revascularization Procedures. Plastic & Reconstructive Surgery. 80(4). 595–602. 26 indexed citations
19.
Rosen, Harvey M., et al.. (1987). Delayed Microcirculatory Hyperpermeability Following Perfusion Washout. Plastic & Reconstructive Surgery. 79(1). 102–107. 13 indexed citations
20.
Rosen, Harvey M., et al.. (1987). The Role of Perfusion Washout in Limb Revascularization Procedures. Plastic & Reconstructive Surgery. 80(4). 603–605. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria A. Rivelli Breakdown of academic impact, for papers by Artur-Aron Weber Breakdown of academic impact, for papers by T Matsushima Breakdown of academic impact, for papers by A. Shino Breakdown of academic impact, for papers by Koh‐ichiro Kinugawa Breakdown of academic impact, for papers by Jose Gasalla-Herraiz Breakdown of academic impact, for papers by Darijana Horvat Breakdown of academic impact, for papers by T. Viganò Breakdown of academic impact, for papers by Leonóra Himer
Rankless by CCL
2026